Expert Review of Endocrinology & Metabolism,
Journal Year:
2023,
Volume and Issue:
18(1), P. 81 - 94
Published: Jan. 2, 2023
ABSTRACTABSTRACTIntroduction
Obesity
is
a
key
target
in
the
treatment
and
prevention
of
diabetes
independently
to
reduce
burden
cardiovascular
disease.
We
reviewed
options
now
available
anticipated
deal
with
obesity.Areas
covered
considered
epidemiology,
genetics,
causation
obesity
relationship
diabetes,
dietary,
pharmaceutical,
surgical
management
condition.
The
literature
search
both
popular
media
via
Google
Search
academic
as
indexed
on
PubMed
terms
including
obesity,
childhood
adipocytes,
insulin
resistance,
mechanisms
satiety,
bariatric
surgery,
GLP-1
receptor
agonists,
SGLT2
inhibitors.Expert
opinion
Although
surgery
has
been
primary
approach
treating
obese
individuals,
emergence
agents
impacting
brain
satiety
centers
promises
effective,
non-invasive
for
individuals
without
diabetes.
agonists
have
assumed
role
significant
weight
loss.
Long-term
results
semaglutide
tirzepatide
are
approaching
success
seen
surgery.
Future
combining
benefits
control
thermogenesis
dissipate
caloric
excess
under
investigation.KEYWORDS:
Obesitytype
2
diabetesprediabetesliraglutidesemaglutidetirzapatide
Article
highlights
majority
patients
suffering
from
type
overweight
or
obeseIn
addition
promoting
development
associated
hypertension;
dyslipidemia;
ischemic
heart
disease;
stroke;
obstructive
sleep
apnea;
asthma;
nonalcoholic
steatohepatitis;
gastroesophageal
reflux
degenerative
joint
disease
back,
hips,
knees,
feet;
infertility
polycystic
ovary
syndrome;
various
malignancies;
depression.The
cause
death
other
risk
factors.Weight
through
lifestyle
modification
cornerstone
diabetes.It
estimated
that
60–70%
adults
attempt
lose
each
year,
but
most
regain
lost
over
long
term.The
greatest
achieving
loss
achieved
variety
techniques.
Mean
(SE)
reductions
percentage
body
at
3
years
were
after
gastric
bypass
25.0%
(2.0%),
followed
by
banding
15.0%
(2.0%)
5.7%
(2.4%)
(P
<
.01).Perioperative
mortality
low.
Complications
need
repeat
interventions
involve
20%
30%
patients.Historically,
pharmacological
therapy
less
successful
than
Metformin,
acarbose,
number
appetite
suppressants,
orlistat
had
only
modest
benefit.The
advent
inhibitors
revolutionary
impact
Both
classes
demonstrated
major
benefit
renal
diabetes.Several
used
treat
Liraglutide
dose
mg
daily
an
approved
agent
indication
several
years.
Semaglutide
superior
effects
head-to-head
studies
liraglutide.
Tirzepatide,
combined
GIP
agonist,
also
recent
patients.Research
ongoing
develop
multireceptor
activity,
targeting
not
just
receptors,
possible
thermogenic
decrease
fat
mass.The
degree
approached
levels
some
studies.The
congestive
failure
diabetes.The
combination
may
herald
new
age
health
impairments.Declaration
interestThe
authors
no
relevant
affiliations
financial
involvement
any
organization
entity
interest
conflict
subject
matter
materials
discussed
manuscript.
This
includes
employment,
consultancies,
honoraria,
stock
ownership
options,
expert
testimony,
grants
patents
received
pending,
royalties.Reviewer
disclosuresPeer
reviewers
this
manuscript
relationships
disclose.Additional
informationFundingThe
Rose
Salter
Medical
Research
Foundation
Association
Diabetes
Investigators.
International Journal of Obesity,
Journal Year:
2024,
Volume and Issue:
48(4), P. 449 - 460
Published: Jan. 11, 2024
Despite
varied
treatment,
mitigation,
and
prevention
efforts,
the
global
prevalence
severity
of
obesity
continue
to
worsen.
Here
we
propose
a
combined
model
obesity,
unifying
paradigm
that
links
four
general
models:
energy
balance
(EBM),
based
on
calories
as
driver
weight
gain;
carbohydrate-insulin
(CIM),
insulin
storage;
oxidation-reduction
(REDOX),
reactive
oxygen
species
(ROS)
altered
metabolic
signaling;
obesogens
(OBS),
which
proposes
environmental
chemicals
interfere
with
hormonal
signaling
leading
adiposity.
We
OBS/REDOX
in
(in
air,
food,
food
packaging,
household
products)
generate
false
autocrine
endocrine
signals,
including
ROS,
subvert
standard
regulatory
mechanisms,
increase
basal
stimulated
secretion,
disrupt
efficiency,
influence
appetite
expenditure
gain.
This
incorporates
data
supporting
EBM
CIM
models,
thus
creating
one
integrated
covers
significant
aspects
all
mechanisms
potentially
contributing
pandemic.
Importantly,
provides
rationale
approach
for
future
preventative
efforts
chemical
exposure
reduction.
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: Feb. 28, 2024
Metabolic
diseases
and
their
complications
impose
health
economic
burdens
worldwide.
Evidence
from
past
experimental
studies
clinical
trials
suggests
our
body
may
have
the
ability
to
remember
metabolic
environment,
such
as
hyperglycemia
or
hyperlipidemia,
thus
leading
chronic
inflammatory
disorders
other
even
after
elimination
of
these
environments.
The
long-term
effects
that
aberrant
metabolism
on
been
summarized
memory
are
found
assume
a
crucial
role
in
states
disease.
Multiple
molecular
mechanisms
collectively
participate
management,
resulting
different
cellular
alterations
well
tissue
organ
dysfunctions,
culminating
disease
progression
affecting
offspring.
elucidation
expansion
concept
provides
more
comprehensive
insight
into
pathogenic
underlying
promises
be
new
target
detection
management.
Here,
we
retrace
history
relevant
research
summarize
its
salient
characteristics.
We
provide
detailed
discussion
by
which
involved
development
at
molecular,
cellular,
levels,
with
emphasis
impact
epigenetic
modulations.
Finally,
present
some
pivotal
findings
arguing
favor
targeting
develop
therapeutic
strategies
for
latest
reflections
consequences
implications
human
diseases.
Circulation Research,
Journal Year:
2025,
Volume and Issue:
136(6), P. 594 - 605
Published: March 13, 2025
Obesity
in
women
is
a
significant
public
health
issue
with
serious
implications
for
cardiovascular-kidney-metabolic
syndrome
and
cardiovascular
disease.
This
complex
challenge
influenced
by
physiological,
hormonal,
socioeconomic,
cultural
factors.
Women
face
unique
weight
management
challenges
due
to
hormonal
changes
during
pregnancy,
perimenopause,
menopause,
which
affect
fat
distribution
increase
risk.
Current
clinical
guidelines
often
overlook
these
sex-specific
factors,
potentially
limiting
the
effectiveness
of
obesity
strategies
women.
review
explores
aspects
obesity’s
pathophysiology,
epidemiological
trends,
associated
comorbidities,
focusing
on
metabolic
complications.
synthesizes
literature
women,
emphasizing
factors
influencing
its
development
progression.
It
examines
limitations
body
mass
index
as
an
measure
alternative
classification
methods.
Additionally
it
investigates
relationship
between
comorbidities
such
diabetes,
hypertension,
dyslipidemia,
focus
postmenopausal
linked
increased
risks
Hormonal
fluctuations
throughout
life
contribute
gain
patterns
specific
increasing
disease
Effective
must
account
variations.
Postmenopausal
are
particularly
affected
obesity-related
Lifestyle
interventions,
pharmacotherapy,
bariatric
surgery
have
shown
efficacy
management,
though
success
rates
vary.
Addressing
requires
comprehensive
approach
that
considers
physiological
life-stage
challenges,
sociocultural
barriers.
Integrating
precision
medicine
emerging
therapies
offers
potential
more
personalized
effective
interventions.
Personalized
consider
women’s
biological
can
enhance
improve
outcomes.
Future
research
practice
should
developing
tailored
address
vulnerabilities
validating
interventions
Nutrients,
Journal Year:
2022,
Volume and Issue:
14(8), P. 1597 - 1597
Published: April 12, 2022
The
obesity
epidemic
shows
no
signs
of
abatement.
Genetics
and
overnutrition
together
with
a
dramatic
decline
in
physical
activity
are
the
alleged
main
causes
for
this
pandemic.
While
they
undoubtedly
represent
contributors
to
problem,
not
able
fully
explain
all
cases
current
trends.
In
context,
body
knowledge
related
exposure
as
yet
underappreciated
obesogenic
factors,
which
can
be
referred
"exposome",
merits
detailed
analysis.
Contrarily
genome,
"exposome"
is
subject
great
dynamism
variability,
unfolds
throughout
individual's
lifetime.
development
precise
ways
capturing
full
spectrum
person
extraordinarily
demanding.
Data
derived
from
epidemiological
studies
linking
excess
weight
elevated
ambient
temperatures,
utero,
intergenerational
effects
well
epigenetics,
microorganisms,
microbiota,
sleep
curtailment,
endocrine
disruptors,
among
others,
suggests
possibility
that
may
work
alone
or
synergistically
several
alternative
putative
global
epidemic.
This
narrative
review
reports
available
evidence
on
drivers
Broadly
based
interventions
needed
better
identify
these
at
same
time
stimulating
reflection
potential
relevance
perpetuation
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(20), P. 12305 - 12305
Published: Oct. 14, 2022
The
World
Health
Organization
(WHO)
refers
to
obesity
as
abnormal
or
excessive
fat
accumulation
that
presents
a
health
risk.
Obesity
was
first
designated
disease
in
2012
and
since
then
the
cost
burden
of
have
witnessed
worrisome
increase.
hypertension
are
closely
interrelated
abdominal
interferes
with
endocrine
immune
systems
carries
greater
risk
for
insulin
resistance,
diabetes,
hypertension,
cardiovascular
disease.
Many
factors
at
interplay
between
hypertension.
They
include
hemodynamic
alterations,
oxidative
stress,
renal
injury,
hyperinsulinemia,
sleep
apnea
syndrome
leptin-melanocortin
pathway.
Genetics,
epigenetics,
mitochondrial
also
play
major
role.
measurement
blood
pressure
obese
patients
requires
an
adapted
cuff
search
other
secondary
causes
is
necessary
higher
thresholds
than
general
population.
Lifestyle
modifications
such
diet
exercise
often
not
enough
control
obesity,
so
far,
bariatric
surgery
constitutes
most
reliable
method
achieve
weight
loss.
Nonetheless,
emergence
new
agents
Semaglutide
Tirzepatide
offers
promising
alternatives.
Finally,
several
molecular
pathways
actively
being
explored,
they
should
significantly
extend
treatment
options
available.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(16), P. 9267 - 9267
Published: Aug. 17, 2022
Chronic
conditions
such
as
obesity,
diabetes,
and
dementia
are
increasing
in
the
United
States
(US)
population.
Knowledge
of
these
chronic
conditions,
preventative
measures,
proper
management
tactics
is
important
critical
to
preventing
disease.
The
overlap
between
becoming
further
elucidated.
These
share
a
similar
origin
through
components
age,
gender,
genetic
epigenetic
predispositions,
depression,
high-fat
Western
diet
(WD)
that
all
contribute
inflammatory
state
associated
with
development
dementia.
This
leads
dysregulation
food
intake
insulin
resistance.
Obesity
often
cornerstone
diabetes
and,
subsequently,
case
type
2
mellitus
(T2DM),
progression
"type
3
(T3DM)".
depression
closely
diabetes.
However,
can
be
avoided
lifestyle
modifications,
by
switching
plant-based
(e.g.,
Mediterranean
(MD)),
physical
activity.
Diet
exercise
not
only
treatment
options.
There
several
surgical
pharmacological
interventions
available
for
prevention.
Current
future
research
within
each
fields
warranted
offers
chance
new
options
better
understanding
pathogenesis
condition.
Frontiers in Endocrinology,
Journal Year:
2022,
Volume and Issue:
13
Published: Nov. 14, 2022
Sedentary
lifestyle
and
consumption
of
high-calorie
foods
have
caused
a
relentless
increase
overweight
obesity
prevalence
at
all
ages.
Its
presently
epidemic
proportion
is
disquieting
due
to
the
tight
relationship
with
metabolic
syndrome
several
other
comorbidities
which
do
call
for
urgent
workarounds.
The
usual
ineffectiveness
present
therapies
failure
prevention
campaigns
triggered
overtime
number
research
studies
unveiled
some
relevant
aspects
genetic
epigenetic
inheritable
profiles.
These
findings
are
revealing
extremely
precious
mainly
serve
as
likely
extra
arrow
allow
clinician’s
bow
achieve
still
hitherto
unmet
preventive
goals.
Evidence
now
exists
that
maternal
obesity/overnutrition
during
pregnancy
lactation
convincingly
appears
associated
disorders
in
offspring
independently
transmission
purely
predisposition.
Even
pre-conception
direct
exposure
either
father
or
mother
gametes
environmental
factors
can
reprogram
architecture
cells.
Such
phenomena
lie
behind
transfer
susceptibility
future
generations
through
mechanism
inheritance.
Moreover,
growing
suggests
such
malnutrition,
hypoxia,
excess
hormones
endocrine
disruptors
early
postnatal
period
may
play
critical
roles
programming
childhood
adipose
tissue
obesity.
A
deeper
understanding
how
inherited
genetics
epigenetics
generate
an
obesogenic
environment
pediatric
age
might
strengthen
our
knowledge
about
pathogenetic
mechanisms
improve
clinical
management
patients.
Therefore,
this
narrative
review,
we
attempt
provide
general
overview
contribution
heritable
patterns
children,
placing
particular
emphasis
on
mother-child
dyad.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(12), P. 9818 - 9818
Published: June 6, 2023
The
comprehensive
anabolic
effects
of
insulin
throughout
the
body,
in
addition
to
control
glycemia,
include
ensuring
lipid
homeostasis
and
anti-inflammatory
modulation,
especially
adipose
tissue
(AT).
prevalence
obesity,
defined
as
a
body
mass
index
(BMI)
≥
30
kg/m2,
has
been
increasing
worldwide
on
pandemic
scale
with
accompanying
syndemic
health
problems,
including
glucose
intolerance,
resistance
(IR),
diabetes.
Impaired
sensitivity
or
IR
paradoxically
leads
diseases
an
inflammatory
component
despite
hyperinsulinemia.
Therefore,
excess
visceral
AT
obesity
initiates
chronic
low-grade
conditions
that
interfere
signaling
via
receptors
(INSRs).
Moreover,
response
IR,
hyperglycemia
itself
stimulates
primarily
defensive
associated
subsequent
release
numerous
cytokines
real
threat
organ
function
deterioration.
In
this
review,
all
components
vicious
cycle
are
characterized
particular
emphasis
interplay
between
both
innate
adaptive
immune
responses
related
obesity.
Increased
accumulation
should
be
considered
main
environmental
factor
responsible
for
disruption
epigenetic
regulatory
mechanisms
system,
resulting
autoimmunity
inflammation.
Frontiers in Immunology,
Journal Year:
2022,
Volume and Issue:
13
Published: July 22, 2022
Endometriosis
is
defined
as
the
presence
of
endometrial-like
glands
and
stroma
located
outside
uterine
cavity.
This
common,
estrogen
dependent,
inflammatory
condition
affects
up
to
15%
reproductive-aged
women
a
well-recognized
cause
chronic
pelvic
pain
infertility.
Despite
still
unknown
etiology
endometriosis,
much
evidence
suggests
participation
epigenetic
mechanisms
in
disease
etiopathogenesis.
The
main
rationale
based
on
fact
that
heritable
phenotype
changes
do
not
involve
alterations
DNA
sequence
are
common
triggers
for
hormonal,
immunological,
disorders,
which
play
key
role
formation
endometriotic
foci.
Epigenetic
regulating
T-cell
responses,
including
methylation
posttranslational
histone
modifications,
deserve
attention
because
tissue-resident
T
lymphocytes
work
concert
with
organ
structural
cells
generate
appropriate
immune
responses
functionally
shaped
by
organ-specific
environmental
conditions.
Thus,
failure
precisely
regulate
cell
transcription
may
result
compromised
immunological
integrity
an
increased
risk
disorders.
coexistence
endometriosis
autoimmunity
well-known
occurrence.
Recent
research
results
indicate
regulatory
(Treg)
number
highly
active
Tregs
macrophages
have
been
found
peritoneal
fluid
from
endometriosis.
Elimination
function
imbalance
between
helper
Th1
Th2
types
reported
endometria
endometriosis-associated
review
aims
present
state
art
recognition
reprogramming
factor
pathophysiology
context
T-cell-related
autoimmunity.
new
potential
therapeutic
approaches
modulation
and/or
adoptive
transfer
will
also
be
outlined.